Welcome to the OPENPUB Journal of Cancer Research & Reviews, an open-access, peer-reviewed journal dedicated to advancing cancer research by providing an interdisciplinary platform for high-quality research and reviews. The journal serves as a vital resource for scientific discoveries in cancer biology, treatment modalities, prevention strategies, and the latest clinical innovations.

Welcome to the OPENPUB Journal of Cancer Research & Reviews, an open-access, peer-reviewed journal dedicated to advancing cancer research by providing an interdisciplinary platform for high-quality research and reviews. The journal serves as a vital resource for scientific discoveries in cancer biology, treatment modalities, prevention strategies, and the latest clinical innovations.

We aim to cover all aspects of cancer research, including molecular biology, early detection techniques, and therapeutic advancements. This journal encourages submissions from a broad range of disciplines, with a focus on providing insight into novel approaches to cancer diagnosis, treatment, and prevention. Topics include but are not limited to:

• Molecular Oncology: Research into the molecular mechanisms driving cancer and the development of targeted therapies.
• Cancer Genetics: Studies on genetic mutations, risk factors, and cancer susceptibility.
• Cancer Immunotherapy: Advancements in immune-based treatments and personalized medicine.
• Chemotherapy and Radiotherapy: Insights into conventional treatment methods and their integration with novel therapies.
• Cancer Diagnostics: New biomarkers, imaging techniques, and early detection methods.
• Prevention and Public Health: Public health initiatives, prevention programs, and epidemiological studies related to cancer.
• Palliative Care and Survivorship: Research on improving the quality of life for cancer patients and survivors.

Our editorial board, made up of world-class researchers and clinicians, ensures the highest standards of peer review and scientific integrity. As an open-access journal, we prioritize rapid dissemination of findings to accelerate the translation of research into clinical practice.

Keywords: Clinical Trials in Cancer, Cancer Biomarkers, Chemotherapy Resistance, Radiotherapy, Cancer Screening, Oncolytic Virus Therapy, Cancer Nanotechnology, Tumor Immunology, Cancer Prevention, Tumor Invasion and Metastasis, Precision Oncology, Immuno-oncology, CAR-T Cell Therapy, Liquid Biopsy, Targeted Therapy, Gene Editing in Cancer, Cancer Stem Cells, Cancer Epigenetics, Cancer Metabolism, Artificial Intelligence in Oncology, Breast Cancer, Lung Cancer, Leukemia, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Hematologic Malignancies, Melanoma, Brain Tumors, Head and Neck Cancer, Cancer Research, Oncology, Cancer Treatment, Cancer Biology, Cancer Immunotherapy, Cancer Diagnosis, Tumor Microenvironment, Molecular Oncology, Cancer Therapy, Cancer Genetics.